Mark J. Ratain to Hematologic Diseases
This is a "connection" page, showing publications Mark J. Ratain has written about Hematologic Diseases.
Connection Strength
0.040
-
Dose-escalation trial of cladribine using five daily intravenous infusions in patients with advanced hematologic malignancies. J Clin Oncol. 1996 Jan; 14(1):188-95.
Score: 0.033
-
Phase I study of adozelesin administered by 24-hour continuous intravenous infusion. J Natl Cancer Inst. 1994 Mar 02; 86(5):368-72.
Score: 0.007